INTRODUCTION: Infantile hemangiomas are the most common benign tumors in children. However, cranial involvement of such lesions is rare. Current treatment options for hemangiomas in various locations that would be endangering or disfiguring include follow-up, surgical removal, or administration of corticosteroids, interferon-α, thalidomide, vincristine, propranolol, and laser therapy. METHODS: We describe an infant who presented with an extensive cranial hemangioma (proven by a biopsy). The child was treated with propranolol. RESULTS: Clinical and radiological follow-up for over a year showed significant reduction in tumor size without adverse clinical symptoms. CONCLUSION: Propranolol is a valid treatment for large cranial hemangiomas, avoiding the risks involved in surgeries.
INTRODUCTION: Infantile hemangiomas are the most common benign tumors in children. However, cranial involvement of such lesions is rare. Current treatment options for hemangiomas in various locations that would be endangering or disfiguring include follow-up, surgical removal, or administration of corticosteroids, interferon-α, thalidomide, vincristine, propranolol, and laser therapy. METHODS: We describe an infant who presented with an extensive cranial hemangioma (proven by a biopsy). The child was treated with propranolol. RESULTS: Clinical and radiological follow-up for over a year showed significant reduction in tumor size without adverse clinical symptoms. CONCLUSION:Propranolol is a valid treatment for large cranial hemangiomas, avoiding the risks involved in surgeries.
Authors: Christine Léauté-Labrèze; Eric Dumas de la Roque; Thomas Hubiche; Franck Boralevi; Jean-Benoît Thambo; Alain Taïeb Journal: N Engl J Med Date: 2008-06-12 Impact factor: 91.245
Authors: Martin Benesch; André O von Bueren; Tobias Dantonello; Katja von Hoff; Torsten Pietsch; Ivo Leuschner; Alexander Claviez; Uta Bierbach; Gabriele Kropshofer; Rudolf Korinthenberg; Norbert Graf; Meinolf Suttorp; Rolf Dieter Kortmann; Carsten Friedrich; Nicolas von der Weid; Peter Kaatsch; Thomas Klingebiel; Ewa Koscielniak; Stefan Rutkowski Journal: J Neurooncol Date: 2012-12-11 Impact factor: 4.130
Authors: Bilal Mirza; William Y Shi; Rahul Phadke; Janice L Holton; Chris Turner; Gordon T Plant; Stefan Brew; Neil Kitchen; Ludvic Zrinzo Journal: World Neurosurg Date: 2012-12-13 Impact factor: 2.104
Authors: Karen M Chisholm; Kay W Chang; Mai T Truong; Shirley Kwok; Rob B West; Amy E Heerema-McKenney Journal: Mod Pathol Date: 2012-06-29 Impact factor: 7.842
Authors: Ibrahim Jalloh; Andrew F Dean; Dominic G O'Donovan; Justin Cross; Matthew R Garnett; Thomas Santarius Journal: Acta Neurochir (Wien) Date: 2014-02-05 Impact factor: 2.216